149 related articles for article (PubMed ID: 17563396)
21. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas.
Balakrishnan A; von Neuhoff N; Rudolph C; Kamphues K; Schraders M; Groenen P; van Krieken JH; Callet-Bauchu E; Schlegelberger B; Steinemann D
Genes Chromosomes Cancer; 2006 Oct; 45(10):883-92. PubMed ID: 16830336
[TBL] [Abstract][Full Text] [Related]
22. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy.
Marcé S; Balagué O; Colomo L; Martinez A; Höller S; Villamor N; Bosch F; Ott G; Rosenwald A; Leoni L; Esteller M; Fraga MF; Montserrat E; Colomer D; Campo E
Clin Cancer Res; 2006 Jun; 12(12):3754-61. PubMed ID: 16778103
[TBL] [Abstract][Full Text] [Related]
23. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
[TBL] [Abstract][Full Text] [Related]
24. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.
Khoury JD; Medeiros LJ; Rassidakis GZ; McDonnell TJ; Abruzzo LV; Lai R
J Pathol; 2003 Jan; 199(1):90-7. PubMed ID: 12474231
[TBL] [Abstract][Full Text] [Related]
25. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival.
Martinez A; Bellosillo B; Bosch F; Ferrer A; Marcé S; Villamor N; Ott G; Montserrat E; Campo E; Colomer D
Am J Pathol; 2004 Feb; 164(2):501-10. PubMed ID: 14742256
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Mitsuhashi N; Kobayashi S; Doki T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Miura S; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e189-97. PubMed ID: 18466288
[TBL] [Abstract][Full Text] [Related]
27. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
Garcia M; Romaguera JE; Inamdar KV; Rassidakis GZ; Medeiros LJ
Cancer; 2009 Mar; 115(5):1041-8. PubMed ID: 19170236
[TBL] [Abstract][Full Text] [Related]
28. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
30. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
[TBL] [Abstract][Full Text] [Related]
31. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Sander S; Bullinger L; Leupolt E; Benner A; Kienle D; Katzenberger T; Kalla J; Ott G; Müller-Hermelink HK; Barth TF; Möller P; Lichter P; Döhner H; Stilgenbauer S
Haematologica; 2008 May; 93(5):680-7. PubMed ID: 18367489
[TBL] [Abstract][Full Text] [Related]
32. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
[TBL] [Abstract][Full Text] [Related]
33. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
34. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival.
Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B
Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
36. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
[TBL] [Abstract][Full Text] [Related]
37. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
[TBL] [Abstract][Full Text] [Related]
38. Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma.
Pscherer A; Schliwka J; Wildenberger K; Mincheva A; Schwaenen C; Döhner H; Stilgenbauer S; Lichter P
FASEB J; 2006 Jun; 20(8):1188-90. PubMed ID: 16636107
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
40. Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.
Hutter G; Scheubner M; Ott G; Zimmermann Y; Hübler K; Roth S; Stilgenbauer S; Kalla J; Stöcklein H; Hiddemann W; Dreyling M
Ann Hematol; 2009 Sep; 88(9):821-8. PubMed ID: 19137297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
